European committee affirms benefits of SGLT-2s while urging healthcare providers to be vigilant and educate patients for signs and symptoms of atypical DKA.
Read More »Resistance Exercise and Appetite Regulation in Type 2 Diabetes
How important is the timing of exercise in affecting appetite hormones?
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #16: Epidemiology and Geography of Type 2 Diabetes Mellitus Part 5 of 5
Obesity and weight gain have consistently been shown to be the one of the strongest modifiable risk factors for diabetes. The ratio of a person’s weight in kilograms divided by the square of their height in meters called the body mass index (BMI) has been used in numerous studies as a surrogate for obesity. In a representative sample of the US population, each unit increase in BMI was associated with a 12% increased risk of T2DM. Compared to people with BMI less than 22 kg/m2 those with BMI of 25–27 kg/m2 had 2.75 times the risk of diabetes, and each kilogram increase in body weight over 10 years was associated with a 4.5% increase in diabetes risk.
Read More »Effectiveness of Insulin Regimens For Patients With Uncontrolled Type 2 Diabetes
Use of degludec/liraglutide vs glargine injections focus of study.
Read More »Diabetes Said to Combat Prostate Cancer
New research shows that patients with type 2 diabetes have a lower risk of having prostate cancer.
Read More »Type 2 Diabetes Treatment Intensifies
Patients with greater disease burden more likely to receive therapy increase.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #15: Epidemiology and Geography of Type 2 Diabetes Mellitus Part 4 of 5
Type 2 diabetes was historically a rare occurrence in children but recent studies have reported marked increases in the prevalence of T2DM in children. Type 2 diabetes was first reported in a population-based study in 1979 of American Indian children in Arizona. This American Indian community has one of the highest rates of T2DM in adults and obesity in both adults and children.
Read More »Get Off the Diabetes Couch
A sedentary lifestyle may lead to type 2 diabetes and metabolic syndrome.
Read More »Empagliflozin: Potential New Approach to Treating T2DM
Empagliflozin is proving to be a strong proponent for monotherapy in patients with T2DM.
Read More »The New Biology of Diabetes
Could study of FOXO transcription factors one day lead to new therapies?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.